Advanced search

Online first
Review paper
Published online: 2024-08-12

open access

View PDF Download PDF file
Page views 261
Article views/downloads 107
Get Citation

Connect on Social Media

Connect on Social Media

Lymph node metastases, sentinel lymph node biopsy, and lymphadenectomy in soft tissue sarcoma — when and why?

Ada Niezgoda12, Anna M. Czarnecka1, Paulina Chmiel12, Maria Krotewicz1, Mateusz Spałek13, Tomasz Świtaj1, Paweł Rogala1, Piotr Rutkowski1
DOI: 10.5603/ocp.100872

Abstract

The spread of soft tissue sarcomas (STS) through the lymphatic system occurs rarely, mainly in epithelioid sarcoma, angiosarcoma, rhabdomyosarcoma, and clear cell sarcoma (CARE). STS subtypes differ in terms of biological behavior. CARE histology and high-grade nodal disease are defined as risk factors in STS. The nodal involvement status in STS patients correlates with the subsequent development of distant metastases. Regional disease is considered clinically distinct from distant metastatic disease in case of recurrence, and it has a better prognosis and better outcomes in terms of long-term survival. Preoperative sentinel lymph node biopsy (SLNB) may be used to identify high-risk patients, as this technique also allows the determination of patients with occult microscopic lymph node disease. The positive result of SLNB may indicate regional lymphadenectomy (LND). Though data on LND in STS are limited, this tool may play a role in multimodal treatment. In the case of STS, a unified diagnosis protocol is needed but followed by an individual treatment approach depending on the results of nodal involvement.

Keywords: sarcomaSTSlymph nodesSLNBlymphadenectomymetastasisprognosismanagement

Article available in PDF format

View PDF Download PDF file

References

  1. Basile G, Mattei JC, Alshaygy I, et al. Curability of patients with lymph node metastases from extremity soft-tissue sarcoma. Cancer. 2020; 126(23): 5098–5108.
    CrossRefPubMed
  2. Brady AC, Picado O, Tashiro J, et al. Lymph Node Sampling and Survival in Child and Adolescent Extremity Soft-Tissue Sarcoma. J Surg Res. 2019; 241: 205–214.
    CrossRefPubMed
  3. Garcia-Ortega DY, Alvarez-Cano A, Clara-Altamirano MA, et al. Should metastatic lymph nodes be considered at the same clinical stage as distant metastasis in soft tissue sarcomas? Cancer Treat Res Commun. 2021; 26: 100268.
    CrossRefPubMed
  4. Miccio JA, Jairam V, Gao S, et al. Predictors of Lymph Node Involvement by Soft Tissue Sarcoma of the Trunk and Extremity: An Analysis of the National Cancer Database. Cureus. 2019; 11(10): e6038.
    CrossRefPubMed
  5. Jacobs AJ, Morris CD, Levin AS. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas. Clin Orthop Relat Res. 2018; 476(3): 589–598.
    CrossRefPubMed
  6. Teterycz P, Czarnecka A, Szmajdzinska A, et al. 1661P Prognostic role of regional lymph node metastases in soft tissue sarcomas. Ann Oncol. 2020; 31: S988–S989.
    CrossRef
  7. Witt RG, Voss RK, Chiang YJ, et al. Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol. 2023; 30(6): 3668–3676.
    CrossRefPubMed
  8. Andreou D, Boldt H, Werner M, et al. Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread--results of a large prospective trial. Ann Oncol. 2013; 24(5): 1400–1405.
    CrossRefPubMed
  9. Moncayo VM, Alazraki AL, Alazraki NP, et al. Sentinel Lymph Node Biopsy Procedures. Semin Nucl Med. 2017; 47(6): 595–617.
    CrossRefPubMed
  10. Nathanson SD, Shah R, Rosso K. Sentinel lymph node metastases in cancer: causes, detection and their role in disease progression. Semin Cell Dev Biol. 2015; 38: 106–116.
    CrossRefPubMed
  11. Hayes AJ, Nixon IF, Strauss DC, et al. UK guidelines for the management of soft tissue sarcomas. Br J Cancer. 2024 [Epub ahead of print].
    CrossRefPubMed
  12. Vibhakar AM, Cassels JA, Botchu R, et al. Imaging update on soft tissue sarcoma. J Clin Orthop Trauma. 2021; 22: 101568.
    CrossRefPubMed
  13. Johannesmeyer D, Smith V, Cole DJ, et al. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013; 206(3): 289–295.
    CrossRefPubMed
  14. Gusho CA, Fice MP, O'Donoghue CM, et al. A Population-based Analysis of Lymph Node Metastasis in Extremity Soft Tissue Sarcoma: An Update. J Surg Res. 2021; 262: 121–129.
    CrossRefPubMed
  15. Blazer DG, Sabel MS, Sondak VK. Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg Oncol. 2003; 12(3): 201–206.
    CrossRefPubMed
  16. Fong Y, Coit DG, Woodruff JM, et al. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg. 1993; 217(1): 72–77.
    CrossRefPubMed
  17. Daigeler A, Kuhnen C, Moritz R, et al. Lymph node metastases in soft tissue sarcomas: a single center analysis of 1,597 patients. Langenbecks Arch Surg. 2009; 394(2): 321–329.
    CrossRefPubMed
  18. Sherman KL, Kinnier CV, Farina DA, et al. Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma. J Surg Oncol. 2014; 110(6): 682–688.
    CrossRefPubMed
  19. Sawamura C, Matsumoto S, Shimoji T, et al. Lymphadenectomy and histologic subtype affect overall survival of soft tissue sarcoma patients with nodal metastases. Clin Orthop Relat Res. 2013; 471(3): 926–931.
    CrossRefPubMed
  20. Martínez-Trufero J, Cruz Jurado J, Hernández-León CN, et al. Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II. Cancer Treat Rev. 2021; 99: 102260.
    CrossRefPubMed
  21. van Akkooi ACJ, Verhoef C, van Geel AN, et al. Sentinel node biopsy for clear cell sarcoma. Eur J Surg Oncol. 2006; 32(9): 996–999.
    CrossRefPubMed
  22. Behranwala KA, A'Hern R, Omar AM, et al. Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol. 2004; 11(7): 714–719.
    CrossRefPubMed
  23. Connolly EA, Bhadri VA, Wake J, et al. Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review. Cancer Med. 2022; 11(8): 1805–1816.
    CrossRefPubMed
  24. Makise N, Yoshida A. CIC-Rearranged Sarcoma. Surg Pathol Clin. 2024; 17(1): 141–151.
    CrossRefPubMed
  25. Antonescu CR, Owosho AA, Zhang L, et al. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases. Am J Surg Pathol. 2017; 41(7): 941–949.
    CrossRefPubMed
  26. Brčić I, Brodowicz T, Cerroni L, et al. Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum. Pathology. 2020; 52(2): 236–242.
    CrossRefPubMed
  27. Jitheesh A, Pai A. When Sarcomas Mimic Lymphomas: A BCOR-Rearranged Sarcoma Case Report. Cureus. 2024; 16(2): e54944.
    CrossRefPubMed
  28. Aranza S, Roydhouse C, Mitchell C, et al. A rare diagnostically challenging case of CIC-DUX4 sarcoma arising in the neck. Pathology. 2023; 55(4): 568–571.
    CrossRefPubMed
  29. Lehane F, Tsikleas G, Bettington A, et al. "Cyst" on the forearm of a 28-year-old female: Case report of a CIC-rearranged sarcoma. J Cutan Pathol. 2019; 46(8): 599–602.
    CrossRefPubMed
  30. Machado I, Cruz J, Lavernia J, et al. Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis. Virchows Arch. 2013; 463(6): 837–842.
    CrossRefPubMed
  31. Aranza S, Roydhouse C, Mitchell C, et al. A rare diagnostically challenging case of CIC-DUX4 sarcoma arising in the neck. Pathology. 2023; 55(4): 568–571.
    CrossRefPubMed
  32. Brady EJ, Hameed M, Tap WD, et al. Imaging features and clinical course of undifferentiated round cell sarcomas with CIC-DUX4 and BCOR-CCNB3 translocations. Skeletal Radiol. 2021; 50(3): 521–529.
    CrossRefPubMed
  33. Chmiel P, Krotewicz M, Szumera-Ciećkiewicz A, et al. Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma. Curr Oncol. 2024; 31(1): 307–323.
    CrossRefPubMed
  34. Czarnecka AM, Sobczuk P, Kostrzanowski M, et al. Epithelioid Sarcoma-From Genetics to Clinical Practice. Cancers (Basel). 2020; 12(8).
    CrossRefPubMed
  35. Al-Refaie WB, Andtbacka RHI, Ensor J, et al. Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer. 2008; 112(8): 1821–1826.
    CrossRefPubMed
  36. Zagars GK, Ballo MT, Pisters PWT, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003; 97(10): 2530–2543.
    CrossRefPubMed
  37. Liu H, Zhang H, Zhang C, et al. Pan-Soft Tissue Sarcoma Analysis of the Incidence, Survival, and Metastasis: A Population-Based Study Focusing on Distant Metastasis and Lymph Node Metastasis. Front Oncol. 2022; 12: 890040.
    CrossRefPubMed
  38. Wang X, Feng J, Li Z, et al. Characteristics and prognosis of embryonal rhabdomyosarcoma in children and adolescents: An analysis of 464 cases from the SEER database. Pediatr Investig. 2020; 4(4): 242–249.
    CrossRefPubMed
  39. Machado I, Cruz J, Lavernia J, et al. Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis. Virchows Arch. 2013; 463(6): 837–842.
    CrossRefPubMed
  40. Mori T, Kobayashi E, Kawai A. [Ⅰ.New TNM Classification of Bone and Soft Tissue Sarcoma-Changes between the 7th and 8th Editions]. Gan To Kagaku Ryoho. 2019; 46(3): 433–436.
    PubMed
  41. Connolly EA, Bhadri VA, Wake J, et al. Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review. Cancer Med. 2022; 11(8): 1805–1816.
    CrossRefPubMed
  42. Keung EZ, Chiang YJ, Voss RK, et al. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol. 2018; 44(1): 170–177.
    CrossRefPubMed
  43. Tunn PU, Andreou D, Illing H, et al. Sentinel node biopsy in synovial sarcoma. Eur J Surg Oncol. 2008; 34(6): 704–707.
    CrossRefPubMed
  44. de Visscher SA, van Ginkel RJ, Wobbes T, et al. Epithelioid sarcoma: Still an only surgically curable disease. Cancer. 2006; 107(3): 606–612.
    CrossRefPubMed
  45. Emori M, Tsuchie H, Nagasawa H, et al. Early Lymph Node Metastasis May Predict Poor Prognosis in Soft Tissue Sarcoma. Int J Surg Oncol. 2019; 2019: 6708474.
    CrossRefPubMed
  46. de Juan Ferré A, Álvarez Álvarez R, Casado Herráez A, et al. SEOM Clinical Guideline of management of soft-tissue sarcoma (2020). Clin Transl Oncol. 2021; 23(5): 922–930.
    CrossRefPubMed
  47. von Mehren M, Kane JM, Agulnik M, et al. Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022; 20(7): 815–833.
    CrossRefPubMed
  48. Park HoY, Chung HW, Yoon MA, et al. Enhancing local recurrence detection in patients with high-grade soft tissue sarcoma: value of short-term Ultrasonography added to post-operative MRI surveillance. Cancer Imaging. 2024; 24(1): 12.
    CrossRefPubMed
  49. Burkhard-Meier A, Jurinovic V, Berclaz LM, et al. Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma. Clin Exp Metastasis. 2024; 41(2): 131–141.
    CrossRefPubMed
  50. Wagner LM, Kremer N, Gelfand MJ, et al. Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial. Cancer. 2017; 123(1): 155–160.
    CrossRefPubMed
  51. Pavlidis ET, Pavlidis TE. New trends in the surgical management of soft tissue sarcoma: The role of preoperative biopsy. World J Clin Oncol. 2023; 14(2): 89–98.
    CrossRefPubMed
  52. Wright S, Armeson K, Hill EG, et al. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012; 204(4): 428–433.
    CrossRefPubMed
  53. Witt RG, Cope B, Erstad DJ, et al. Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases. Ann Surg Oncol. 2022; 29(11): 7092–7100.
    CrossRefPubMed
  54. Ostafiichuk VK, Korovin SI, Kukushkina NM. 1663P Local recurrence and 5-year survival control of primary localized sarcoma of the soft tissues of the extremities and body. Ann Oncol. 2020; 31(Suppl 4): S989.
    CrossRef
  55. van Praag VM, Rueten-Budde AJ, Jeys LM, et al. A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC). Eur J Cancer. 2017; 83: 313–323.
    CrossRefPubMed
  56. Ikuta K, Nishida Y, Imagama S, et al. The current management of clear cell sarcoma. Jpn J Clin Oncol. 2023; 53(10): 899–904.
    CrossRefPubMed
  57. Sobanko JF, Meijer L, Nigra TP. Epithelioid sarcoma: a review and update. J Clin Aesthet Dermatol. 2009; 2(5): 49–54.
    PubMed
  58. Ognjanovic S, Linabery AM, Charbonneau B, et al. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. 2009; 115(18): 4218–4226.
    CrossRefPubMed
  59. Miwa S, Yamamoto N, Hayashi K, et al. Recent Advances and Challenges in the Treatment of Rhabdomyosarcoma. Cancers. 2020; 12(7): 1758.
    CrossRef
  60. Alcorn KM, Deans KJ, Congeni A, et al. Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging. J Pediatr Surg. 2013; 48(9): 1903–1906.
    CrossRefPubMed
  61. Gazendam AM, Popovic S, Munir S, et al. Synovial Sarcoma: A Clinical Review. Curr Oncol. 2021; 28(3): 1909–1920.
    CrossRefPubMed
  62. Wang L, Lao IW, Yu L, et al. Clinicopathological features and prognostic factors in angiosarcoma: A retrospective analysis of 200 patients from a single Chinese medical institute. Oncol Lett. 2017; 14(5): 5370–5378.
    CrossRefPubMed
  63. Cao J, Wang J, He C, et al. Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res. 2019; 9(11): 2303–2313.
    PubMed
  64. Oliveira Monteiro A, Branco Ferreira I, César A, et al. Cutaneous Angiosarcoma in an Unusual Location and Without Predisposing Factors. Eur J Case Rep Intern Med. 2020; 7(12): 001939.
    CrossRefPubMed
  65. Fujisawa Y, Yoshino K, Fujimura T, et al. Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor. Front Oncol. 2018; 8: 46.
    CrossRefPubMed
  66. Ramakrishnan N, Mokhtari R, Charville GW, et al. Cutaneous Angiosarcoma of the Head and Neck-A Retrospective Analysis of 47 Patients. Cancers (Basel). 2022; 14(15).
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note